Indian stocks: Visit www.stage2stocks.com →

Heartbeam, Inc.

Stage 4 · Declining · week 30

As of Oct 22, 2026, Heartbeam is in Stage 4, the downtrend phase, now in week 30 (since Mar 24, 2026). It closed at $0.40, 88.4% below its 52-week high and below its 200-day average, which is falling.

HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside… More about the company

$0.40
-2.90% today
$22.4M · Micro cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Is BEAT early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 18w
S1 15w
S2 16w
S4 31w
S4 30w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S1 2w → S4 18w → S1 15w → S2 16w → S3 11w → S2 10w → S3 4w → S4 31w → S1 8w → S2 1w → S1 1w → S4 2w → S3 1w → S2 10w → S3 3w → S4 30w current
Total tracked: 165 weeks across 16 stage runs.

BEAT among Health Information Services34th of 41 by relative strength

All 41 →
Stocks in Health Information Services ranked by relative strength, with stage and one-month change
#StockStageRS1M
1AMWLStage 2 · wk 2597+7.4%
2HNGEStage 2 · wk 2096+19.1%
3BTSGStage 3 · wk 894+9.1%
4NRCStage 3 · wk 493−0.1%
5SOPHStage 2 · wk 2491−12.7%
6HTFLStage 2 · wk 1087+17.0%
7HSTMStage 2 · wk 1777+20.3%
8OMCLStage 4 · wk 1070+12.5%
…34BEATStage 4 · wk 3013+2.3%
vs 52W High
-88.4%
$0.36 lo$3.44 hi
88.4% below 52W high, deep Stage 4 damage
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 30
1w13w26w
Week 30, extended decline
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-56.9%
200 DMA: $0.92 · sloping down
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
0.07x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
↗ ⇈
Short-term trend rising gently, and accelerating
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+2.3%
3M
-22.3%
6M
-55.4%
YTD
-83.6%
1Y
-75.7%
Scan Membership
Breakout Watch
Latest: 2024-11-05
3 appearances in last 60 days. First seen: 2022-10-06.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S4
Wk 30 · Vol 0.07x
2026-10-21S4
Wk 30 · Vol 0.04x
2026-10-20S4
Wk 30 · Vol 0.06x
2026-10-19S4
Wk 29 · Vol 0.08x
2026-10-16S4
Wk 29 · Vol 0.05x
2026-10-15S4
Wk 29 · Vol 0.13x
2026-10-14S4
Wk 29 · Vol 0.11x
2026-10-13S4
Wk 29 · Vol 0.17x
2026-10-12S4
Wk 28 · Vol 0.15x
2026-10-09S4
Wk 28 · Vol 0.17x
2026-10-08S4
Wk 28 · Vol 0.40x
2026-10-07S4
Wk 28 · Vol 0.57x
Moving averages & range
50 DMA
$0.45
200 DMA
$0.92
52W High
$3.44
52W Low
$0.36
5D Low
$0.40
Resistance levels (recent highs)
20d High
$0.65
60d High
$0.65
120d High
$1.04
250d High
$3.44
Next resistance
+64.3%
to 20d High
ROE
-328.4%
Profit margin 0.0%
Dividend Yield
0.00%
P/B 2.7

Heartbeam: quick answers

What stage is Heartbeam in?

As of Oct 22, 2026, Heartbeam (BEAT) is in Stage 4, the downtrend phase. It entered Stage 4 on Mar 24, 2026 and is in week 30. What the four stages mean

Is Heartbeam in an uptrend?

No. Heartbeam is in a Stage 4 downtrend. It trades 56.9% below its 200-day average, which is falling.

How far is Heartbeam from its 52-week high?

Heartbeam closed at $0.40 on Oct 22, 2026, 88.4% below its 52-week high of $3.44. Its 52-week low is $0.36.

How has Heartbeam performed over the past year?

As of Oct 22, 2026, Heartbeam is down 75.7% over the past year and down 83.6% so far in 2026.

Which sector and industry is Heartbeam in?

Heartbeam is in the Health Information Services industry, part of the Health Care sector.

About this companyHealth Care· Health Information Services

HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms. HeartBeam, Inc. was incorporated in 2015 and is based in Santa Clara, California.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.